Myoderm
Myonex (formerly Myoderm) is a family-owned clinical trial supply and commercial pharmaceutical services company operating nine GMP/GDP facilities across the US, UK, Germany, and France. It serves 267+ pharma, biotech, and CRO clients with integrated drug sourcing, packaging, distribution, compounding pharmacy, bioservices, and its proprietary CTRx® patient supply platform.
- Company typePrivate
- Founded1931
- HeadquartersNorristown, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Myoderm does
Myoderm, operating globally as Myonex, is a family-owned clinical trial supply and commercial pharmaceutical services company. Originally a Philadelphia-area retail pharmacy tracing to 1865 (acquired by Morris Cohen in 1931), the company has evolved over three generations into an integrated clinical trial supply partner serving pharmaceutical sponsors, biotechnology companies, and contract research organizations (CROs) across North America and Europe. The company rebranded from Myoderm to Myonex in September 2020 to reflect its expanded global scope. It operates nine owned facilities across the US (Horsham, PA headquarters; Newark, DE), UK (Leicester), Germany (Berlin), and France (Le Haillan, Reims clinical and commercial, Bailly-Romainvilliers), and reports serving 267+ pharma and biotech clients.
Myonex's core offerings span clinical packaging, labeling and distribution; drug and ancillary sourcing from 60+ countries; pharmacy services through its wholly-owned 50-state US compounding pharmacy SaveWay; bioservices including cryogenic storage down to -196°C for cell and gene therapies and ATMPs; and contract commercial packaging. The flagship proprietary platform, CTRx®, combines prescription card services, global pharmacy dispensing, and centralized local drug supply into a single integrated solution accessed through the myCTcentral® portal, with a US pharmacy network exceeding 70,000 locations. Underlying capabilities include GMP/GDP-certified facilities, QP release services for the EU/UK, NABP Drug Distributor Accreditation, Qualiopi-certified training, and Just-In-Time labeling supported by supply chain simulation tools.
Revenue is generated primarily through project-based, quote-priced contracts for clinical trial supply services and managed commercial packaging services, supplemented by transaction-based fees for CTRx® prescription processing and consulting engagements. The go-to-market is sales-led through enterprise field sales targeting pharma sponsors, biotechs, and CROs, reinforced by event participation (CPHI, CTS, OCT, GCSG) and direct consultation requests. Customer engagements are typically multi-year contracts with a dedicated expert Project Manager assigned across the full scope, and exclusive manufacturer partnerships (e.g., Adalvo) provide differentiated drug access. Customer mix spans enterprise pharma (e.g., Debiopharm, URGO, Genethon), biotech (Lytix Biopharma, Brenus Pharma), CROs (Lexitas, CRS-hVIVO), and nonprofits (Leukemia & Lymphoma Society).
Myoderm firmographics
Firmographics- Name
- Myoderm
- Legal name
- Myonex, LLC
- Website
- https://myonex.com
- Company type
- Private
- Founded year
- 1931
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Myonex (formerly Myoderm) is a family-owned clinical trial supply and commercial pharmaceutical services company operating nine GMP/GDP facilities across the US, UK, Germany, and France. It serves 267+ pharma, biotech, and CRO clients with integrated drug sourcing, packaging, distribution, compounding pharmacy, bioservices, and its proprietary CTRx® patient supply platform.
- Ownership category
- akta.pro rank
Myoderm industry classification
Industry- Product category
- Clinical Trial Supply Services
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
- akta.pro secondary industries
- Specialty Pharmacy & Biologics Distribution (CRAOAHAD), Packaging, Labeling & Serialization Services (biologics/cold chain) (HLAAAKAJ)
Keywords
Where Myoderm is headquartered
LocationHeadquarters
- HQ city
- Norristown
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
Myoderm business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Clinical Trial Supply Services: Integrated clinical trial supply services including packaging, labeling, distribution, drug sourcing, pharmacy services, and bioservices. Revenue generated through project fees, service contracts, and per-transaction pricing for clinical trial sponsors and CROs.
- Commercial Pharmaceutical Packaging Services: Contract packaging and repackaging services for marketed pharmaceutical products including primary packaging (blistering and bottling), secondary packaging, serialization, and commercial storage for brand and generic drugs.
- Consulting Services: Pharmacist consulting, supply chain optimization, and ultra-cold chain consulting services provided to pharma and biotech companies.
- CTRx® Solution: Prescription card services and global pharmacy dispensing generating fees based on prescription processing and local drug supply coordination for clinical trials.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based pricing for clinical trial supply and commercial packaging services |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
Myoderm product offering
Product offeringCore offering
Myoderm (operating as Myonex) provides integrated clinical trial supply and commercial pharmaceutical services for pharmaceutical, biotechnology, and CRO clients globally. Core offerings include comparator and ancillary drug sourcing, primary and secondary clinical packaging and labeling, global distribution, QP release services, bioservices (ATMP/cell & gene therapy storage and cryogenic biostorage down to -196°C), a fully-owned US 50-state compounding pharmacy (SaveWay), commercial packaging/serialization, and a proprietary CTRx® patient drug-supply solution combining prescription cards, global pharmacy dispensing, and centralized local drug supply.
Product overview
Myonex is an integrated clinical trial supply and commercial pharmaceutical services company offering a comprehensive suite of solutions. The core offerings include CTRx® (a prescription card, pharmacy dispensing, and local drug supply platform), Clinical Packaging/Labeling/Distribution, Drug & Ancillary Sourcing, Pharmacy Services (via SaveWay Compounding Pharmacy), Bioservices (biostorage and ATMP supply chain), and Commercial Packaging. These services are supplemented by Consulting Services covering pharmacist consulting, supply chain optimization, and ultra-cold chain consulting. The myCTcentral® portal provides the technology interface for CTRx, while the Sourcing Comparison Calculator helps sponsors evaluate sourcing models. The company operates from facilities in the US, UK, Germany, and France.
Differentiator
Problem solved
Functional benefit
Brands
- SaveWay Compounding Pharmacy: A Myonex company providing US 50-state compounding pharmacy services including sterile and non-sterile compounding, Direct to Patient dispensing for clinical trials
- CTRx
- myCTcentral
Products and services
- CTRx®
Quantifiable outcome
- Up to 65% cost saving compared to traditional central sourcing model (Debiopharm Phase III trial case study)
- +6 more outcomes
Companies that use Myoderm
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles1 record
Myoderm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Myoderm partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and supporting.
- The Leukemia & Lymphoma Society (LLS)coreThe Leukemia & Lymphoma Society selected Myonex as its preferred partner to support patients in the LLS-sponsored Beat AML® Master Clinical Trial through CTRx® solution. Myonex manages medication support program ensuring uninterrupted access to commercial medications and comprehensive patient financial assistance. This partnership underscores Myonex's ability to respond to critical patient needs and foster mission-aligned partnerships supporting blood cancer research.
- AdalvocoreAdalvo, a global B2B pharmaceutical company and one of Europe's leading generic and biosimilar suppliers, expanded its exclusive partnership with Myonex as the exclusive provider of Adalvo products for clinical trial use globally. Both parties expanded the agreement to include multiple new assets for global markets. Myonex helps pharmaceutical companies, biotechs, and CROs adopt generic and biosimilar medicines in clinical trials, reducing costs and ensuring adequate, timely supply. Adalvo has commercial partnerships in more than 130 countries and over 140 commercial partners globally.
- DebiopharmcoreMyonex designed and executes a hybrid local and central sourcing and labeling strategy for Debiopharm's Phase III clinical trial (Debio 4126-301) involving 70 investigational sites in 20 countries. The collaboration includes Just-In-Time labeling in EU, CTRx® local sourcing in 6 countries (Spain, France, UK, Brazil, Israel, USA), and myCTcentral® portal implementation. Projected up to 65% cost saving compared to traditional central sourcing model.
- Strategic Depot Network PartnerssupportingMyonex maintains a strategic partner depot network spanning Europe, North America, Latin America (LATAM), Asia Pacific (APAC), Middle East, and Africa to complement its own owned facilities for clinical distribution. Also leverages specialized and qualified 3PLs for ultra-cold logistics under Myonex expert supervision, trained in ADR (road transport) and IATA (air transport) regulations.
- Home Healthcare Providers (HHPs)supportingHome Healthcare Providers serve as distribution partners for Direct-to-Patient (DtP) clinical trial medication delivery in decentralized clinical trials. Myonex coordinates with HHPs for temperature-controlled distribution and logistics, patient sample collection, and unused drug returns as part of its DCT support services.
- Data Privacy Framework Certifying BodiessupportingMyonex is committed to EU-U.S. Data Privacy Framework, UK Extension to EU-U.S. DPF, and Swiss-U.S. Data Privacy Framework. FTC has jurisdiction over Myonex's compliance with these frameworks. This commitment ensures lawful data transfers from EU, UK, and Switzerland to the US.
Scale indicators11 records
Recent moves13 records
Expansion highlights8 records
Myoderm competitors and assessment
Company assessmentDirect peers
- Marken (UPS Healthcare): Marken is a global clinical trial supply chain and logistics provider offering direct-to-patient services, comparator sourcing, and biopharma cold chain logistics. Owned by UPS Healthcare, it competes directly with Myonex's clinical distribution and bioservices lines.
- Biocair: Biocair is a specialist global courier for clinical trial shipments and biopharmaceutical logistics with deep cold chain expertise including cryogenic and ultra-cold transport. Comparable to Myonex's bioservices and clinical distribution operations for cell/gene therapy and ATMP trials.
- Clinigen Group: Clinigen is the closest direct peer, specializing in clinical trial supply, comparator sourcing, and managed access programs for pharma and biotech sponsors globally. Like Myonex, it offers integrated clinical supply solutions targeting the same sponsor and CRO buyer base.
- Sharp Packaging Services (Stericycle): Sharp Packaging Services provides commercial and clinical pharmaceutical packaging, serialization, and labeling services from GMP facilities globally. Directly comparable to Myonex's Reimbursement commercial packaging and Reims-based packaging operations.
- PCI Pharma Services: PCI Pharma Services is a leading CDMO specializing in clinical and commercial packaging, labeling, serialization, and global drug supply. Direct competitor in Myonex's clinical packaging, labeling, and commercial packaging service lines with comparable GMP/GDP infrastructure.
Broad incumbents
- DHL Supply Chain (Life Sciences & Healthcare): DHL Supply Chain operates a global Life Sciences and Healthcare division with GMP-certified warehousing, clinical trial distribution, and cold chain capabilities. Broader incumbent with significant overlap in clinical distribution and comparator drug logistics.
- Eurofins Scientific: Eurofins provides bioanalytical, central lab, and clinical trial support services globally through its pharma services division. A broader life sciences services incumbent that overlaps with Myonex's bioservices and clinical testing adjacencies.
- Thermo Fisher Scientific (PPD Clinical Research): Thermo Fisher, through PPD, provides end-to-end clinical trial services including clinical supply, packaging, and comparator sourcing as part of a broader CRO and life sciences tools portfolio. Represents the vertically integrated mega-vendor threat in clinical supply.
- Recipharm: Recipharm is a European-headquartered CDMO offering pharmaceutical development, clinical supply, and commercial manufacturing services. Comparable to Myonex in the European clinical packaging and supply space, particularly relevant for the German, French, and UK markets where Myonex operates.
- Catalent: Catalent is a large global CDMO offering clinical supply services, primary packaging, and comparator sourcing alongside its broader drug development and biologics manufacturing portfolio. A broader incumbent with overlapping clinical supply capabilities but operating at much larger scale.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat7 records
Key risks5 records
Key highlights7 records
Customer concentration
Myoderm social profiles
Digital presenceMyoderm compliance and trust
Trust signalCompliance10 records
Myoderm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Myoderm leadership team
Management profileNumber of profiles
Profiles8 records
Myoderm subsidiaries and ownership
Company hierarchySubsidiaries3 records
Myoderm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Myoderm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Myoderm
What does Myoderm do?
Myoderm (operating as Myonex) provides integrated clinical trial supply and commercial pharmaceutical services for pharmaceutical, biotechnology, and CRO clients globally. Core offerings include comparator and ancillary drug sourcing, primary and secondary clinical packaging and labeling, global distribution, QP release services, bioservices (ATMP/cell & gene therapy storage and cryogenic biostorage down to -196°C), a fully-owned US 50-state compounding pharmacy (SaveWay), commercial packaging/serialization, and a proprietary CTRx® patient drug-supply solution combining prescription cards, global pharmacy dispensing, and centralized local drug supply.
Is Myoderm a public or private company?
Myoderm is a private company. It is classified as family owned and is currently operating.
When was Myoderm founded?
Myoderm was founded in 1931. It employs 11 to 50 people.
Where is Myoderm based?
Myoderm is headquartered in Norristown, United States, in the North America region.
How does Myoderm make money?
Four revenue lines are on record. Clinical Trial Supply Services are the primary driver. The others are commercial Pharmaceutical Packaging Services, consulting Services and CTRx® Solution.
Who are Myoderm's main competitors?
Direct peers on record are Marken (UPS Healthcare), Biocair, Clinigen Group, Sharp Packaging Services (Stericycle) and PCI Pharma Services. Broad incumbents are DHL Supply Chain (Life Sciences & Healthcare), Eurofins Scientific, Thermo Fisher Scientific (PPD Clinical Research), Recipharm and Catalent.
Does Myoderm have an API?
No public API is recorded for Myoderm.
What industry is Myoderm in?
Myoderm's product category is Clinical Trial Supply Services. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of CRAOAHAD, Specialty Pharmacy & Biologics Distribution. Its NAICS code is 325412 and its SIC code is 5122.